Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update outlines a first-in-human study of S230815 in pediatric participants with KCNT1-related developmental and epileptic encephalopathy, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • S230815

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Epileptic Encephalopathy | Phase 1, Phase 2 | Status: RECRUITING